MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Net decrease in cashand cash...-$5,062K Net cash provided by(used in) operating...$36K Net cash used inoperating activities-$5,011K Net cash (used in)provided by financing...-$44K Net cash used ininvesting activities-$7K Canceled cashflow$36K Accrued expenses$1,114K Amortization of debt discountand debt issuance...$445K Accounts payable$365K Stock-based compensation$208K Non-cash interestexpense$203K Amortization of right-of-useasset$177K Depreciation$4K Net cash used inoperating activities -...-$5,047K Offering costs in advanceof sale of common...$44K Acquisition of property andequipment$7K Canceled cashflow$2,516K Net loss fromcontinuing operations-$6,225K Inventory$750K Prepaid expenses andother current assets$341K Lease liabilities-$128K Other assets$86K Change in fair value ofderivative liability$33K
Cash Flow

Valion Bio, Inc. (VBIO)

Valion Bio, Inc. (VBIO)

source: myfinsight.com